Diagnosing IBS with ibs-smart® and patients to consider

Dr. Mark Pimentel​

Professor of Medicine at Geffen School of Medicine and Cedars-Sinai
Medical Center in Los Angeles, California.

  • Validated IBS biomarkers
    provide a diagnosis of
    inclusion.
  • Antibody blood testing offers
    an organic confirmation of an
    IBS diagnosis.
  • A positive result indicates the
    root cause of the patient’s IBS
    was an instance of infectious
    gastroenteritis.

With ibs-smart®, you can rule in IBS using a blood test and determine the original cause.

Used early in your diagnostic protocol, ibs-smart® can help you focus diagnostic workups.

Patients to consider

  • Have IBS symptoms with a diarrheal component
  • Have no alarm symptoms (e.g., blood in stool)
  • May or may not remember having had food poisoning
  • ​May have factors that increase risks associated with invasive procedures

ibs-smart® has broad applicability to patients with diarrheal symptoms.

Up to 60% of patients with diarrheal IBS symptoms could be suffering from post-infectious IBS.